Hoth Therapeutics to Utilize AI for Drug Discovery via Joint Development Agreement with Wise Systems International

June 10, 2024

DENVER, Colo., Jun 10, 2024 (247marketnews.com)- Hoth Therapeutics, Inc. (NASDAQ:HOTH) entered into a joint development agreement with Wise Systems International SRL to utilize the BioNeMo AI platform of Nvidia, whch provides researchers and developers a fast and easy way to build and integrate state-of-the-art generative AI applications across the entire drug discovery pipeline.

Wise Systems International SRL’s Robert Antofe stated, “We’re excited to work with Hoth and leverage our existing AI expertise to help bring further value to both companies through the development of Hoth Therapeutics AI initiatives.”

Robb Knie, Chief Executive Officer of Hoth Therapeutics, commented, “We believe the Nvidia BioNeMo platform is best in class and with SRL’s assistance we can better grow our IP, leverage our existing pipeline and deliver exciting novel therapeutics to patients in need.”

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (HOTH)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.